Clinical Trials List
2012-05-01 - 2018-12-03
Phase III
Terminated9
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 曾鈞宏 Division of Neurology
- Ching-Hua Lu Lu Division of Neurology
- Hui-Chun Huang Division of Neurology
- Chung-Hsiang Liu Division of Neurology
- Yi-Chien Yang Division of Neurology
- Jui-Cheng Chen Division of Neurology
- Kang-Hsu Lin Division of Neurology
- Ming-Kuei Lu Division of Neurology
- Fu-Yu Lin Division of Neurology
- Wei-Shih Huang Division of Neurology
- Yu-Wan Yang Division of Neurology
- Yuh-Cherng Guo Division of Neurology
- Yi-Ting Hsu Division of Neurology
- Kuan-Fei Chen Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 葉旭霖 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 李崇維 Division of Radiology
- SHIN-JOE YEH Division of Neurology
- SUNG-CHUN TANG Division of Neurology
- LI-KAI TSAI Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Pi-Shan Sung Division of Neurology
- 莊明宗 Division of Neurology
- Han-Wei Huang Division of Neurology
- 蘇慧貞 Division of Neurology
- 謝函潔 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 許致善 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
0 participants
-
Global
400 participants
